Skip to main content
Safi Shahda, MD, Oncology, Indianapolis, IN

Safi Shahda MD

Gastrointestinal Cancer, Hematologic Oncology


Assistant Professor, Medicine, IN Univ Sch of Med

Join to View Full Profile
  • 535 Barnhill DrRm 473Indianapolis, IN 46202

  • Phone+1 317-274-5000

Dr. Shahda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 2007 - 2010
  • Damascus University Faculty of Medicine
    Damascus University Faculty of MedicineClass of 2004

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2011 - 2023

Awards, Honors, & Recognition

  • Danny Danielson Inaugural Innovative Translational Award Hoosier Oncology Group

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Phase I Study of EUS-Guided Photodynamic Therapy for Locally Advanced Pancreatic Cancer  
    John M Dewitt, Bert O'Neil, Amikar Sehdev, Safi Shahda, Gastrointestinal Endoscopy
  • Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX  
    Olumide Gbolahan, Amikar Sehdev, Howard H Wu, Safi Shahda, Clinical Cancer Research

Lectures

  • A phase I study of the APE1 protein inhibitor APX3330 in patients with advanced solid tumors. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Prospective trial of preoperative FOLFIRINOX in patients with resectable pancreatic ductal adenocarcinoma (PDAC): Report of early endpoints. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018

Authored Content

  • Two Months of Therapy: A Case of Pathologic Complete Response to Chemo-Immunotherapy in a Patient with Metastatic Colorectal CancerDecember 2017

Other Languages

  • Arabic

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: